Acotec Scientific Holdings Limited

SEHK:6669 Stock Report

Market Cap: HK$1.9b

Acotec Scientific Holdings Past Earnings Performance

Past criteria checks 1/6

Acotec Scientific Holdings has been growing earnings at an average annual rate of 56%, while the Medical Equipment industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 27.1% per year. Acotec Scientific Holdings's return on equity is 1.1%, and it has net margins of 3.1%.

Key information

56.0%

Earnings growth rate

52.9%

EPS growth rate

Medical Equipment Industry Growth13.7%
Revenue growth rate27.1%
Return on equity1.1%
Net Margin3.1%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 46% Undervalued

Mar 21
An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 46% Undervalued

We Think Acotec Scientific Holdings (HKG:6669) Can Easily Afford To Drive Business Growth

Nov 17
We Think Acotec Scientific Holdings (HKG:6669) Can Easily Afford To Drive Business Growth

Acotec Scientific Holdings Limited's (HKG:6669) Intrinsic Value Is Potentially 42% Above Its Share Price

Oct 20
Acotec Scientific Holdings Limited's (HKG:6669) Intrinsic Value Is Potentially 42% Above Its Share Price

Acotec Scientific Holdings (HKG:6669) Has More To Do To Multiply In Value Going Forward

Sep 24
Acotec Scientific Holdings (HKG:6669) Has More To Do To Multiply In Value Going Forward

An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued

Jul 01
An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued

Revenue & Expenses Breakdown
Beta

How Acotec Scientific Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:6669 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2347414181185
30 Sep 2346938184191
30 Jun 2346361186197
31 Mar 2342966173190
31 Dec 2239670161184
30 Sep 2236717140170
30 Jun 22339-35120157
31 Mar 22338-24109144
31 Dec 21304-79116141
30 Sep 21285-76126136
30 Jun 21266-74136131
31 Mar 21228-81129113
31 Dec 20194-4410683
31 Dec 19125235725

Quality Earnings: 6669 has a large one-off loss of CN¥21.9M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: 6669's current net profit margins (3.1%) are lower than last year (17.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6669 has become profitable over the past 5 years, growing earnings by 56% per year.

Accelerating Growth: 6669's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 6669 had negative earnings growth (-79.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (-10.4%).


Return on Equity

High ROE: 6669's Return on Equity (1.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.